Summary of Purpose
The primary objective of this study is to examine the safety profile of Eliquis in Korean nonvalvular atrial fibrillation patients.Read More →
The following dates are available for this trial. Trial information last updated on 27 October 2017.
|10 Jul 2013||21 Jun 2013||29 Sep 2017||29 Sep 2017||1 Oct 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bristol-Myers Squibb Lead
- Observation: Case-Only
- Perspective: Prospective
- Sampling: Non-Probability Sample
- Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:
- First line of the email MUST contain NCT# and Site #.